ProBio and Kun Tuo announce CDMO-CRO collaboration for advanced therapies
ProBio and Kun Tuo announced a strategic collaboration combining manufacturing, development and clinical operations expertise for advanced therapies, aimed at accelerating investigator-initiated trials and clinical execution in China.